Analyst consensus rating
AnaptysBio Analyst Rating: Strong Buy
Direct answer
AnaptysBio's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $87.25.
Forecast evidence checked November 16, 2026.
Get free AnaptysBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.25
- Average price target
- $87.25
- High price target
- $140.00
- Low price target
- $60.00
- Low target gap
- +29.7%
- Target upside
- +88.6%
- High target gap
- +202.7%
- Target range width
- 173%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- November 16, 2026
- Valid through
- November 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for AnaptysBio?
AnaptysBio has a verified Strong Buy consensus. The same dataset has an average price target of $87.25.
How far are AnaptysBio's low and high targets from the recorded price?
The low target implies +29.7%, while the high target implies +202.7%.
How many analysts are included in AnaptysBio's consensus?
The verified consensus includes 8 analysts.
How is AnaptysBio's target upside or downside calculated?
The average target of $87.25 is divided by the recorded price of $46.25, then one is subtracted to produce +88.6%. This does not guarantee a future return.
When was AnaptysBio's analyst forecast verified?
The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.